Patents by Inventor ANDREW HANNA

ANDREW HANNA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240372374
    Abstract: Systems and methods for managing varying loads that can be applied to a dual cell bank battery include a dual cell bank battery including primary battery cell pack and a protective battery cell pack, wherein the protective battery cell pack at least partially encapsulates the primary battery cell pack. A battery management system determines which battery cell pack (either the primary battery cell pack or the protective battery cell pack) should be enabled to receive the load.
    Type: Application
    Filed: May 6, 2024
    Publication date: November 7, 2024
    Applicant: SAFIRE TECHNOLOGY GROUP, INC.
    Inventors: Michael GRUBBS, Andrew HANNA, Nader SHOKAIR
  • Patent number: 12056866
    Abstract: A method for inspecting nominally identical workpieces with manufacturing tolerances involves feeding a workpiece to an inspection device; applying a simultaneous translatory and rotational movement to the workpiece via the inspection device while illuminating the workpiece; repeatedly taking camera images of the workpiece during the simultaneous translatory and rotational movement as the workpiece moves across a camera window, the camera images consisting of pixels; setting workpiece parameters based on size and shape of the workpiece; assembling a composite image from the camera images based on the workpiece parameters; determining numerical brightness scores of the workpiece, comparing the determined numerical brightness scores with known numerical brightness scores; assigning a discrepancy score; setting a discrepancy score threshold; determining that the workpiece passes inspection when the discrepancy score is below the discrepancy score threshold; and that the workpiece fails the inspection when the di
    Type: Grant
    Filed: October 28, 2021
    Date of Patent: August 6, 2024
    Assignee: MECTRON ENGINEERING COMPANY, INC.
    Inventor: Andrew Hanna
  • Publication number: 20230136456
    Abstract: A method for inspecting nominally identical workpieces with manufacturing tolerances involves feeding a workpiece to an inspection device; applying a simultaneous translatory and rotational movement to the workpiece via the inspection device while illuminating the workpiece; repeatedly taking camera images of the workpiece during the simultaneous translatory and rotational movement as the workpiece moves across a camera window, the camera images consisting of pixels; setting workpiece parameters based on size and shape of the workpiece; assembling a composite image from the camera images based on the workpiece parameters; determining numerical brightness scores of the workpiece, comparing the determined numerical brightness scores with known numerical brightness scores; assigning a discrepancy score; setting a discrepancy score threshold; determining that the workpiece passes inspection when the discrepancy score is below the discrepancy score threshold; and that the workpiece fails the inspection when the di
    Type: Application
    Filed: October 28, 2021
    Publication date: May 4, 2023
    Inventor: Andrew Hanna
  • Publication number: 20220185767
    Abstract: Preparation and characterization of novel tamibarotene forms suitable for pharmaceutical compositions in drug delivery systems for the treatment of cancer stem cells. The tamibarotene compositions can be used for the safe and effective treatment of human diseases including a variety of cancers, cancer stem cells, drug resistant cancers, and used as a radio sensitizer.
    Type: Application
    Filed: April 1, 2020
    Publication date: June 16, 2022
    Inventors: Mazen HANNA, Manomi PERERA, Jiyu YAN, Andrew HANNA
  • Patent number: 11319311
    Abstract: Synthesis and characterization of novel DACT forms suitable for pharmaceutical compositions in drug delivery systems to treat cancer in humans or a warm-blooded mammals. The novel forms include but not limited to cocrystals, salts, solvates of salts, and mixtures thereof.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: May 3, 2022
    Assignee: TRANSGENEX NANOBIOTECH, INC.
    Inventors: Mazen Hanna, Manomi Perera, Jiyu Yan, Andrew Hanna
  • Patent number: 11053254
    Abstract: Synthesis and characterization of novel crystalline mitomycin C forms suitable for pharmaceutical compositions in drug delivery systems to treat human or warm-blooded diseases.
    Type: Grant
    Filed: February 11, 2019
    Date of Patent: July 6, 2021
    Assignee: TRANSGENEX NANOBIOTECH INC.
    Inventors: Mazen Hanna, Manomi Perera, Jiyu Yan, Andrew Hanna
  • Publication number: 20210053963
    Abstract: Synthesis and characterization of novel DACT forms suitable for pharmaceutical compositions in drug delivery systems to treat cancer in humans or a warm-blooded mammals. The novel forms include but not limited to cocrystals, salts, solvates of salts, and mixtures thereof.
    Type: Application
    Filed: February 11, 2019
    Publication date: February 25, 2021
    Inventors: Mazen HANNA, Manomi PERERA, Jiyu YAN, Andrew HANNA
  • Publication number: 20210002209
    Abstract: Synthesis and characterization of novel tamibarotene forms suitable for pharmaceutical compositions in drug delivery systems to treat human or warm-blooded mammal diseases.
    Type: Application
    Filed: February 11, 2019
    Publication date: January 7, 2021
    Inventors: Mazen HANNA, Manomi PERERA, Jiyu YAN, Andrew HANNA
  • Publication number: 20200323949
    Abstract: Preparation and characterization of novel DACT forms suitable for pharmaceutical compositions in drug delivery systems for humans.
    Type: Application
    Filed: April 9, 2020
    Publication date: October 15, 2020
    Inventors: Mazen HANNA, Manomi PERERA, Jiyu YAN, Andrew HANNA
  • Publication number: 20190381046
    Abstract: The human body is mediated by a large number of chemicals and chemical processes where imbalances can result in abnormal conditions affecting part or all of the human body. Artificial drugs addressing specific diseases by targeting specific chemical imbalance(s) and/or process(es). For example, tofactinib is a JAK-STAT signaling pathway inhibitor beneficial for treating autoimmune diseases whilst baclofen acts as an agonist of GABA receptors. However, these are each prescribed in oral form leading to reduced efficacy or absorption by other regions of the patient. Accordingly, the inventor has established alternate dosing formats such a topical creams allowing local direct application allowing specific targeted delivery to the appropriate region of the patient's body as well their use, in the instances of tofactinib and baclofen, for the treatment of other diseases or conditions.
    Type: Application
    Filed: May 17, 2019
    Publication date: December 19, 2019
    Inventor: ANDREW HANNA
  • Publication number: 20190282591
    Abstract: The human body is mediated by a large number of chemicals and chemical processes where imbalances can result in an abnormal condition that affects part or all of the human body. Amongst these conditions are hair loss and male impotence or erectile dysfunction, both of which can have psychological consequences for the patient and others as they can be tied to relationship difficulties and self-image. 5?-reductase Type II inhibitors prevent DHT production and reduce androgen activity in key tissues such as prostate and scalp. Similarly, an inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) can lead to improved vasodilation and blood flow. It would be beneficial to provide patients with either of these treatments within a topical cream form allowing localized targeted delivery.
    Type: Application
    Filed: March 18, 2019
    Publication date: September 19, 2019
    Inventors: ANDREW HANNA, JONATHAN HUZA
  • Publication number: 20190248800
    Abstract: Synthesis and characterization of novel crystalline mitomycin C forms suitable for pharmaceutical compositions in drug delivery systems to treat human or warm-blooded diseases.
    Type: Application
    Filed: February 11, 2019
    Publication date: August 15, 2019
    Inventors: Mazen HANNA, Manomi PERERA, Jiyu YAN, Andrew HANNA
  • Patent number: 9688078
    Abstract: An apparatus, method and non-transitory computer readable medium for printing on a spherical object are disclosed. For example, the apparatus includes a print head, at least two wheels, wherein each one of the at least two wheels rotates around a single axis, at least one ball support coupled to a mechanical arm, wherein the at least one ball support rotates 360 degrees around and is positioned to secure the spherical object against the at least two wheels and a controller in communication with the print head and the at least two wheels to rotate the spherical object via the at least two wheels into a position to print via the print head.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: June 27, 2017
    Assignee: Xerox Corporation
    Inventors: Roberto A. Irizarry, Carlos Manuel Terrero, Donald R. Fess, Brian Andrew Hanna, Lynn C. Saxton